期刊文献+
共找到649篇文章
< 1 2 33 >
每页显示 20 50 100
Constraint-induced movement therapy promotes motor function recovery and downregulates phosphorylated extracellular regulated protein kinase expression in ischemic brain tissue of rats 被引量:5
1
作者 Bei Zhang Qiang He +4 位作者 Ying-ying Li Ce Li Yu-long Bai Yong-shan Hu Feng Zhang 《Neural Regeneration Research》 SCIE CAS CSCD 2015年第12期2004-2010,共7页
Motor function impairment is a common outcome of stroke.Constraint-induced movement therapy(CIMT)involving intensive use of the impaired limb while restraining the unaffected limb is widely used to overcome the effe... Motor function impairment is a common outcome of stroke.Constraint-induced movement therapy(CIMT)involving intensive use of the impaired limb while restraining the unaffected limb is widely used to overcome the effects of'learned non-use'and improve limb function after stroke.However,the underlying mechanism of CIMT remains unclear.In the present study,rats were randomly divided into a middle cerebral artery occlusion(model)group,a CIMT+model(CIMT)group,or a sham group.Restriction of the affected limb by plaster cast was performed in the CIMT and sham groups.Compared with the model group,CIMT significantly improved the forelimb functional performance in rats.By western blot assay,the expression of phosphorylated extracellular regulated protein kinase in the bilateral cortex and hippocampi of cerebral ischemic rats in the CIMT group was significantly lower than that in the model group,and was similar to sham group levels.These data suggest that functional recovery after CIMT may be related to decreased expression of phosphorylated extracellular regulated protein kinase in the bilateral cortex and hippocampi. 展开更多
关键词 nerve regeneration constraint-induced movement therapy mitogen-activated proteinkinase signaling system brain ischemia locomotion recovery CORTEX hippocampus middle cerebralartery occlusion foot fault test balance beam walking RATS NSFC grants neural regeneration
下载PDF
Blood–brain barrier and laser technology for drug brain delivery
2
作者 Oxana V.Semyachkina-Glushkovskaya Arkady S.Abdurashitov +3 位作者 Elena I.Saranceva Eketerina G.Borisova Alexander A.Shirokov Nikita V.Navolokin 《Journal of Innovative Optical Health Sciences》 SCIE EI CAS 2017年第5期27-38,共12页
Here,we discuss an important problem in medicine as development of efctive strategies for brain drug delivery.This problem is related to the blood-brain barrier(BBB),which is a“customs”controlling the entrance of di... Here,we discuss an important problem in medicine as development of efctive strategies for brain drug delivery.This problem is related to the blood-brain barrier(BBB),which is a“customs”controlling the entrance of different molecules from blood into the brain protecting the normal function of central nervous system(CNS).We show three interfaces of anatomical side of BBB and two functional types of BBB一physical and transporter barriers.Although this protective mechanism is essential for health of CNS,it also creates a hindrance to the entry of drugs into the brain.The BBB was discovered over 100 years ago but till now,there is no efective methods for brain drug delivery.There ane more than 70 approaches for overcoming BBB incuding physical,chenical and biological techniques but all of these tools have limitation to be widely used in clinical practice due to invasi venes,challenge in performing,very costly or lim-itation of drug concentration.Photodynamic therapy(PDT)is usual clinical method of surgical navigation for the resection of brain tumor and anti-cancer therapy.Nowadays,the application of PDT is considered as a potential promising tool for brain drug delivery via opening of BBB.Here,we show the first sucoessful experimental results in this field discussing the adventures and disadv antages of PDT-related BBB disruption as well as altematives to overcome these limitations and possi ble mechanisms with new pathways for brain clearance via gly mphatic and lymphatic systems. 展开更多
关键词 Blood-brain barrier laser technologies photodynamic therapy brain drug delivery
下载PDF
New Developments in Drug Therapy and Research of Cerebral Vasospasm
3
作者 Eleftherios Archavlis Peter Ulrich Mario Carvi YNievas 《Open Journal of Modern Neurosurgery》 2013年第4期72-93,共22页
In this manuscript a comprehensive coverage of recent developments in the drug therapy of vasospasm while providing the background information that neuroscientists need to understand its rationale. The range of new ag... In this manuscript a comprehensive coverage of recent developments in the drug therapy of vasospasm while providing the background information that neuroscientists need to understand its rationale. The range of new agents available for treatment of cerebral vasospasm is expanding rapidly along with rapid advances in pharmacology and physiology that are uncovering the mechanisms of this disease. Although there are many publications for treatment of cerebral vaso-spasm, most are focusing on different aspects of vasospasm treatment and many have limited value due to insufficient quality. Moreover, the complexity of this, in many cases deleterious condition, is enormous and the information needed to understand drug effects is accordingly often not readily available in a single source. A number of pharmacological and medical therapies are currently in use or being investigated in an attempt to reverse cerebral vasospasm, but only a few have proven to be useful. Current research efforts promise the eventual production of new medical therapies. At last, recommendations for the use of different treatment stages based on currently available clinical data are provided. 展开更多
关键词 Cerebral Vasospasm drug therapy Subarachnoid Hemorrhage Delayed Cerebral ischemia New Developments TREATMENT
下载PDF
严重下肢缺血患者围手术期的合理用药
4
作者 刘莹 都丽萍 +1 位作者 唐筱婉 郑月宏 《血管与腔内血管外科杂志》 2024年第4期389-394,共6页
严重下肢缺(CLI)血患者常合并多种慢性疾病,血运重建围手术期的药物管理是疾病治疗的重要内容,不合理的多重用药直接影响患者的治疗结局。本研究针对CLI患者围手术期常见的用药问题进行探讨,重点关注围手术期血栓的预防与治疗、基础疾... 严重下肢缺(CLI)血患者常合并多种慢性疾病,血运重建围手术期的药物管理是疾病治疗的重要内容,不合理的多重用药直接影响患者的治疗结局。本研究针对CLI患者围手术期常见的用药问题进行探讨,重点关注围手术期血栓的预防与治疗、基础疾病防治与多重用药管理、镇痛方案制定与调整,以期为临床医师和药师给患者制定个体化用药方案提供参考。 展开更多
关键词 严重下肢缺血 围手术期 合理用药 抗栓治疗
下载PDF
基于数据挖掘对中医药治疗CKD合并脑卒中的组方用药分析
5
作者 祝昌昊 郭杏林 +3 位作者 杨精华 刘远航 王耀光 唐阁 《北京联合大学学报》 CAS 2024年第4期71-76,共6页
基于数据挖掘方法探讨中医药治疗慢性肾脏病(CKD)合并脑卒中(CS)的临床用药规律。收集2017年10月至2022年10月天津中医药大学第一附属医院门诊治疗CKD合并CS的处方,建立中药处方数据库。统计分析用药频次、性味及归经,对处方中的药物进... 基于数据挖掘方法探讨中医药治疗慢性肾脏病(CKD)合并脑卒中(CS)的临床用药规律。收集2017年10月至2022年10月天津中医药大学第一附属医院门诊治疗CKD合并CS的处方,建立中药处方数据库。统计分析用药频次、性味及归经,对处方中的药物进行聚类分析,利用SPSS Modeler 18 Apriori算法对所有药物进行关联分析。最终纳入544个处方,涉及中药258味,总用药频次8 886次。药性以寒性、温性、平性居多;药味以苦味、甘味、辛味为主;归经多为脾经、肝经;得出13个关联组合药对和5个核心药物组合。中医药对CKD合并CS患者的治疗,根据气虚血瘀、脾肾两虚的病机特点,主要采用健脾益气、补肾活血的组方用药。 展开更多
关键词 慢性肾脏病 脑卒中 数据挖掘 药物组合 脑肾同治
下载PDF
脑类器官在药物研发中的研究进展
6
作者 王靓 夏隆阔 张建民 《基础医学与临床》 CAS 2024年第9期1208-1213,共6页
近年来,随着再生医学与组织工程学的飞速发展,脑类器官作为一种创新的体外模型系统,逐渐成为神经科学研究和药物研发领域的热点。脑类器官通过模拟人类大脑的复杂结构和功能,在体外重现了大脑发育的关键过程,为理解神经系统疾病机制、... 近年来,随着再生医学与组织工程学的飞速发展,脑类器官作为一种创新的体外模型系统,逐渐成为神经科学研究和药物研发领域的热点。脑类器官通过模拟人类大脑的复杂结构和功能,在体外重现了大脑发育的关键过程,为理解神经系统疾病机制、评估药物疗效及毒性提供了前所未有的平台。本文综述了脑类器官技术的最新进展,特别是其在药物研发中的应用,并探讨了该领域面临的挑战与未来发展方向。 展开更多
关键词 脑类器官 疾病模型 药物筛选 精准治疗
下载PDF
从肠道菌群探讨健脾益智法治疗缺血性脑卒中的机制研究
7
作者 林宇星 冯珂 《中国医药指南》 2024年第18期135-139,共5页
中医脾与脑相关理论是健脾益智法治疗缺血性脑卒中的理论基础,而肠道菌群-肠-脑轴是脾脑相关理论的微观机制体现。肠道菌群因定植于肠道,与中医脾脏有着天然的相关性:脾主运化与肠道菌群的消化、吸收作用相关,脾胃气机升降与肠道菌群促... 中医脾与脑相关理论是健脾益智法治疗缺血性脑卒中的理论基础,而肠道菌群-肠-脑轴是脾脑相关理论的微观机制体现。肠道菌群因定植于肠道,与中医脾脏有着天然的相关性:脾主运化与肠道菌群的消化、吸收作用相关,脾胃气机升降与肠道菌群促进肠蠕动相关;脾主为卫与肠道菌群促进免疫系统的发育与功能的成熟相关。肠道菌群属于中医脾藏功能范畴,为治疗缺血性脑卒中提供了新的思路。从肠道菌群的角度来看,健脾益智法治疗缺血性脑卒中具有坚实的理论及现实依据,健脾益智法治疗缺血性脑卒中值得展开深入研究。 展开更多
关键词 肠道菌群 健脾益智法 缺血性脑卒中 脾脑相关理论
下载PDF
药物治疗在肝切除术中预防缺血再灌注损伤的研究进展
8
作者 杨尚明 雷杰 +1 位作者 陈鹏 尹娇莲 《数理医药学杂志》 CAS 2024年第6期446-452,共7页
肝切除术中常采用肝门阻断和控制中心静脉压的方法减少出血,保证手术视野清晰,从而使手术顺利进行,但在肝门阻断和开放过程中会导致肝脏缺血再灌注损伤(hepatic ischemia-reperfusion injury,HIRI)、胃肠道淤血、肠源性细菌移位等问题... 肝切除术中常采用肝门阻断和控制中心静脉压的方法减少出血,保证手术视野清晰,从而使手术顺利进行,但在肝门阻断和开放过程中会导致肝脏缺血再灌注损伤(hepatic ischemia-reperfusion injury,HIRI)、胃肠道淤血、肠源性细菌移位等问题。因此,围术期采取各种措施减轻因肝门阻断引起的HIRI进而提高手术的安全性成为肝切除术的研究热点。缺血预处理、亚低温处理、药物治疗、抗凋亡基因治疗等方法应运而生,其中药物治疗具有可操作性强、相对安全、临床上易操作等优势,因而受到广泛关注。本文对有助于改善HIRI的部分代表药物及作用机制进行总结,为HIRI的临床诊治提供参考。 展开更多
关键词 肝脏缺血再灌注损伤 肝切除术 药物治疗 防治策略
下载PDF
Suppressing Wnt signaling of the blood-tumor barrier to intensify drug delivery and inhibit lipogenesis of brain metastases
9
作者 Yang Tong Pei An +10 位作者 Puxian Tang Rui Mu Yuteng Zeng Hang Sun Mei Zhao Ziyan Lv Pan Wang Wanjun Han Chunshan Gui Xuechu Zhen Liang Han 《Acta Pharmaceutica Sinica B》 SCIE CAS CSCD 2024年第6期2716-2731,共16页
Lipogenesis is often highly upregulated in breast cancer brain metastases to adapt to intracranial low lipid microenvironments.Lipase inhibitors hold therapeutic potential but their intra-tumoral distribution is often... Lipogenesis is often highly upregulated in breast cancer brain metastases to adapt to intracranial low lipid microenvironments.Lipase inhibitors hold therapeutic potential but their intra-tumoral distribution is often blocked by the blood-tumor barrier(BTB).BTB activates its Wnt signaling to maintain barrier properties,e.g.,Mfsd2a-mediated BTB low transcytosis.Here,we reported VCAM-1-targeting nano-wogonin(W@V-NPs)as an adjuvant of nano-orlistat(O@V-NPs)to intensify drug delivery and inhibit lipogenesis of brain metastases.W@V-NPs were proven to be able to inactivate BTB Wnt signaling,downregulate BTB Mfsd2a,accelerate BTB vesicular transport,and enhance tumor accumulation of O@V-NPs.With the ability to specifically kill cancer cells in a lipid-deprived environment with IC_(50) at 48 ng/mL,W@V-NPs plus O@V-NPs inhibited the progression of brain metastases with prolonged survival of model mice.The combination did not induce brain edema,cognitive impairment,and systemic toxicity in healthy mice.Targeting Wnt signaling could safely modulate the BTB to improve drug delivery and metabolic therapy against brain metastases. 展开更多
关键词 LIPOGENESIS brain metastases Blood-tumor barrier Wnt signaling drug delivery Fatty acid synthase NANOPARTICLES Combination therapy
原文传递
Therapeutic potential of stem cells in subarachnoid hemorrhage
10
作者 Hideki Kanamaru Hidenori Suzuki 《Neural Regeneration Research》 SCIE CAS 2025年第4期936-945,共10页
Aneurysm rupture can result in subarachnoid hemorrhage,a condition with potentially severe consequences,such as disability and death.In the acute stage,early brain injury manifests as intracranial pressure elevation,g... Aneurysm rupture can result in subarachnoid hemorrhage,a condition with potentially severe consequences,such as disability and death.In the acute stage,early brain injury manifests as intracranial pressure elevation,global cerebral ischemia,acute hydrocephalus,and direct blood–brain contact due to aneurysm rupture.This may subsequently cause delayed cerebral infarction,often with cerebral vasospasm,significantly affecting patient outcomes.Chronic complications such as brain volume loss and chronic hydrocephalus can further impact outcomes.Investigating the mechanisms of subarachnoid hemorrhage-induced brain injury is paramount for identifying effective treatments.Stem cell therapy,with its multipotent differentiation capacity and anti-inflammatory effects,has emerged as a promising approach for treating previously deemed incurable conditions.This review focuses on the potential application of stem cells in subarachnoid hemorrhage pathology and explores their role in neurogenesis and as a therapeutic intervention in preclinical and clinical subarachnoid hemorrhage studies. 展开更多
关键词 delayed cerebral ischemia early brain injury matricellular protein NEUROGENESIS stem cell therapy subarachnoid hemorrhage
下载PDF
获得性脑损伤患者多重耐药菌感染现状及其对脑功能的影响
11
作者 胡小珍 汪浙炯 +1 位作者 杨璐 毛雅君 《浙江实用医学》 2024年第2期97-101,共5页
目的调查获得性脑损伤康复住院患者多重耐药菌(MDRO)感染特征,并分析其对脑功能的影响。方法回顾性调查浙江省中医药大学附属第一医院2021年6月~2023年5月收治的获得性脑损伤康复住院患者334例,记录入院时多重耐药菌感染情况,将患者分为... 目的调查获得性脑损伤康复住院患者多重耐药菌(MDRO)感染特征,并分析其对脑功能的影响。方法回顾性调查浙江省中医药大学附属第一医院2021年6月~2023年5月收治的获得性脑损伤康复住院患者334例,记录入院时多重耐药菌感染情况,将患者分为MDRO组96例和非MDRO组238例,并在入院和出院时通过格拉斯哥昏迷量表(GCS)、Barthel指数(BI)进行脑功能评估。结果96例MDRO组共采集到204份微生物标本,分别来源于痰液(152/204,74.5%)、尿液(46/204,22.5%)、伤口分泌物(6/204,2.9%),耐碳青霉烯肠杆菌科细菌(CRZ)为最主要MDRO类型,病原菌前三位是铜绿假单胞菌、肺炎克雷伯菌、鲍曼不动杆菌。两组患者功能量表评分结果显示,MDRO组入院及出院时的功能障碍程度高于非MDRO组(P<0.01),且经过住院康复治疗后,两组出院时的GCS、Barthel指数均有改善(P<0.01)。结论28.7%的康复科获得性脑损伤患者在入院时存在多重耐药菌感染,主要来源于呼吸系统感染,最主要MDRO类型为CRE,其脑功能明显低于未感染患者,故今后在MDRO防控基础上,确保MDRO患者的康复治疗效果,以期改善患者的脑功能预后。 展开更多
关键词 获得性脑损伤 多重耐药菌 康复治疗 脑功能
下载PDF
低强度超声促进药物递送的作用机制及研究进展
12
作者 朱文武 杨辉 +2 位作者 胡凯 严国飞 王帆 《中国生物医学工程学报》 CAS CSCD 北大核心 2024年第4期477-488,共12页
近年来,低强度超声促进药物递送的相关研究发展迅速,其应用涵盖多个给药场景,包括经皮给药(超声导入术)、声动力治疗以及血脑屏障开放等。从这3个视角入手,阐述了低强度超声促进药物递送的作用机制,包括热效应、空化效应、机械效应及生... 近年来,低强度超声促进药物递送的相关研究发展迅速,其应用涵盖多个给药场景,包括经皮给药(超声导入术)、声动力治疗以及血脑屏障开放等。从这3个视角入手,阐述了低强度超声促进药物递送的作用机制,包括热效应、空化效应、机械效应及生理调节效应等诸多生物效应,强调了局部空化作用和机械作用的重要性。此外,通过引用相关研究成果,展示了低强度超声在药物递送中的有效性,并指出了需进一步解决的相关问题,如药物释放的可控性与临床治疗的安全性,最后,概述了超声技术与纳米材料相结合,有望拓展药物递送的创新路径,为临床治疗提供更多有效安全的治疗方案。 展开更多
关键词 低强度超声 药物递送 经皮给药 声动力治疗 血脑屏障开放
下载PDF
MECT联合药物治疗精神分裂症患者的效果及对血清BDNF、GFAP、PRL水平的影响
13
作者 朱虹 宋婷 《中国医学创新》 CAS 2024年第19期1-6,共6页
目的:探讨无抽搐电休克疗法(MECT)联合药物治疗精神分裂症患者的效果及对血清脑源性神经营养因子(BDNF)、胶质纤维酸性蛋白(GFAP)、催乳素(PRL)水平的影响。方法:纳入2021年1月—2023年5月江西省精神病院收治的82例精神分裂症患者,遵照... 目的:探讨无抽搐电休克疗法(MECT)联合药物治疗精神分裂症患者的效果及对血清脑源性神经营养因子(BDNF)、胶质纤维酸性蛋白(GFAP)、催乳素(PRL)水平的影响。方法:纳入2021年1月—2023年5月江西省精神病院收治的82例精神分裂症患者,遵照随机数字表法将其分为观察组及对照组,各41例。对照组采用利培酮+奥氮平抗精神药物治疗方案,观察组在对照组基础上加用MECT干预。比较两组治疗前后精神状态[阳性与阴性症状量表(PANSS)]、认知状态[蒙特利尔认知评估量表(MoCA)]、记忆功能[韦氏记忆量表(WMS)]、执行功能[威斯康星卡片分类测验(WCST)]、血清指标(BDNF、GFAP、PRL)及不良反应发生情况。结果:治疗后,两组PANSS(阳性症状、阴性症状、一般精神病理评分)、WCST(错误应答数、首次分类应答数)、GFAP、PRL水平均较治疗前降低,且观察组水平均低于对照组,差异均有统计学意义(P<0.05)。治疗后,两组MoCA评分、WMS(再认、图片、联想、背数记忆评分)、WCST(完成分类数、正确应答数、概念水平百分数)及BDNF水平均较治疗前升高(P<0.05),且观察组水平均高于对照组,差异均有统计学意义(P<0.05)。两组不良反应比较,差异无统计学意义(P>0.05)。结论:采用MECT联合抗精神药物治疗效果确切,可明显改善患者精神症状、认知、记忆及执行等功能障碍,改善脑营养状态,且安全性良好。 展开更多
关键词 无抽搐电休克疗法 药物治疗 精神分裂症 脑源性神经营养因子 胶质纤维酸性蛋白 催乳素
下载PDF
脑电生物反馈辅助治疗慢性精神分裂症的效果
14
作者 蔡云 邹志伟 肖翔 《四川生理科学杂志》 2024年第8期1743-1745,共3页
目的:探讨慢性精神分裂症经脑电生物反馈辅助治疗后的疗效及对认知、社会功能的影响。方法:选取2022年1月至2023年9月我院确诊并接受治疗的慢性精神分裂症患者60例为本次研究的对象,其中30例患者接受抗精神病药物治疗,归为对照组,另30... 目的:探讨慢性精神分裂症经脑电生物反馈辅助治疗后的疗效及对认知、社会功能的影响。方法:选取2022年1月至2023年9月我院确诊并接受治疗的慢性精神分裂症患者60例为本次研究的对象,其中30例患者接受抗精神病药物治疗,归为对照组,另30例在抗精神病药物基础上进行脑电生物反馈疗法,归为观察组。比较两组的临床疗效(临床疗效总评量表-疾病严重程度(Clinical Global Impression-SI,CGI-SI))、脑电活动特征(异常不自主运动量表(Abnormal Involuntary Movement Scale,AIMS))、症状改善情况(现状精神病症状检查(Present State Examination,PSE))、生活质量(日常生活评定量表(Activity of Daily Living Scale,ADL))及社会功能(社会功能缺点挑选量表(Social Disability Screening Schedule,SDSS))。结果:治疗后两组CGI-SI评分、AIMS评分、PSE各维度评分、ADL评分及SDSS评分均显著改善(P<0.05),且观察组各项评分均明显优于对照组(P<0.05)。结论:通过对比分析发现,脑电生物反馈疗法联合药物治疗后,患者临床表现、不自主运动症状及认知功能均可得到明显缓解,而且其生活能力及社会功能也得到不同程度的改善,可作为慢性精神分裂症的有效治疗方案。 展开更多
关键词 脑电生物反馈疗法 药物治疗 慢性精神分裂症 疗效 脑电活动特征 认知功能 社会功能
下载PDF
Houshiheisan compound prescription protects neurovascular units after cerebral ischemia 被引量:7
15
作者 Haizheng Wang Lei Wang +3 位作者 Nan Zhang Qi Zhang Hui Zhao Qiuxia Zhang 《Neural Regeneration Research》 SCIE CAS CSCD 2014年第7期741-748,共8页
Houshiheisan is composed of wind-dispelling (chrysanthemun fower, divaricate saposhnikovia root, Manchurian wild ginger, cassia twig, Szechwan lovage rhizome, and platycodon root) and deficiency-nourishing (ginseng... Houshiheisan is composed of wind-dispelling (chrysanthemun fower, divaricate saposhnikovia root, Manchurian wild ginger, cassia twig, Szechwan lovage rhizome, and platycodon root) and deficiency-nourishing (ginseng, Chinese angelica, large-head atractylodes rhizome, Indian bread, and zingiber) drugs. In this study, we assumed these drugs have protective effects against cerebral ischemia, on neurovascular units. Houshiheisan was intragastrically administered in a rat model of focal cerebral ischemia. Hematoxylin-eosin staining, transmission electron microscopy, immu- nofluorescence staining, and western blot assays showed that Houshiheisan reduced pathological injury to the ischemic penumbra, protected neurovascular units, visibly up-regtflated neuronal nuclear antigen expression, and down-regulated amyloid precursor protein and amyloid-[3 42 expression. Wind-dispelling and deficiency-nourishing drugs maintained NeuN expression to varying degrees, but did not affect amyloid precursor protein or amyloid-~ 42 expression in the ischemic penumbra. Our results suggest that the compound prescription Houshiheisan effectively suppresses abnormal amyloid precursor protein accumulation, reduces amyloid substance depo- sition, maintains stabilization of the internal environment of neurovascular units, and minimizes injury to neurovascular units in the ischemic penumbra. 展开更多
关键词 nerve regeneration brain injury cerebral ischemia Houshiheisan wind-dispelling dru-gs deficiency-nourishing drugs neurovascular units amyloid precursor protein jS-amyloid neuronalnuclear antigen NSFC grant neural regeneration
下载PDF
Tall gastrodis tuber combined with antiepileptic drugs repairs abnormal perfusion foci in focal epilepsy 被引量:2
16
作者 Weimin Wang Zhenyu Fan +6 位作者 Yongqin Zhang Yuxia Yang Yaqing Liu Xiaoli Dang Wenjun Song Yinping Wu Jiang Ye 《Neural Regeneration Research》 SCIE CAS CSCD 2013年第3期208-217,共10页
One hundred patients with focal epilepsy were recruited for the present study and their seizures controlled with antiepileptic drugs. The patients then orally received a capsule of tall gastrodis tuber powder, a tradi... One hundred patients with focal epilepsy were recruited for the present study and their seizures controlled with antiepileptic drugs. The patients then orally received a capsule of tall gastrodis tuber powder, a traditional Chinese drug, and underwent single photon emission computed tomography, long-term electroencephalogram, and CT/MRI. Blood drug levels were monitored throughout the study. Before treatment with tall gastrodis tuber, 35 of the 100 cases had abnormal CT/MRI scans; 79 cases had abnormal single photon emission computed tomography images; 86 cases had abnormal electroencephalogram; and a total of 146 abnormal perfusion foci were observed across the 100 subjects. After treatment, the number of patients with normal single photon emission computed tomography images increased by 12; normal electroencephalogram was observed in an additional 27 cases and the number of patients with epileptiform discharge decreased by 29 (34% of 86); the total number of abnormal perfusion foci decreased by 52 (36%) and changes in abnormal loci were visible in 65 patients. These changes indicate that the administration of tall gastrodis tuber in combination with antiepileptic drugs repairs abnormal perfusion foci in patients with focal epilepsy Our results demonstrate that traditional Chinese drugs can repair abnormal perfusion foci and, as such, are a promising new pathway in the treatment of focal epilepsy. 展开更多
关键词 neural regeneration traditional Chinese medicine neuroimaging brain injury tall gastrodis tuber antiepileptic drugs combination therapy focal epilepsy abnormal perfusion focus single photonemission computed tomography long-term vigilance-controlled electroencephalogram region ofinterest grant-supported paper photographs-containin^l paper: neuoreaeneration
下载PDF
Effects of neuroprotectant cocktails on focal cerebral ischemia in rats 被引量:4
17
作者 潘殿卿 李志梅 李春岩 《中国临床康复》 CSCD 2003年第5期842-844,T002,共4页
AIM:To investigate whether cocktail theraphy combined with of neuroprotectants may have more advantages over single agents in treating focal cerebral ischemic cascade.METHODS:With the use of suture occlusin techique,t... AIM:To investigate whether cocktail theraphy combined with of neuroprotectants may have more advantages over single agents in treating focal cerebral ischemic cascade.METHODS:With the use of suture occlusin techique,the right middle cerebral artery in rats was occluded.Tirty minutes later,Frutose 1,6 diphosphate(FDP) (50 mg/kg,n=20), MK 801(1 mg/kg,n=20) and N acetylcystein (NAC)(150 mg/kg,n=20) were singly or combinantly infused intraperitoneally.At the same time the cocktail treated group(n=20)were infused the above agents combinationly and the control group(n=20)were infused normal saline intraperitoneally.6 hours and 24 hours after focal cerebral ischemia the animals were weighted and neurologically assessed on 5 point scale.The animals were killed,brains were stained 2,3,5 triphenyltetrazolium chloride for assessment of the infarct volume and then embedden onto slides with paraffin for morphological assessment and terminal transferase dUTP nick ending labeling(TUNEL )were carried out for apoptosis and immunohistochemistry were carried out to investigate the changes in bcl 2.RESULTS:All Neuroprotectants decreased volume of infarction (P< 0.05,F test).While cocktail treated group showed more distinct decrease than other groups(P< 0.05,F test).FDP treated group did not decrease the apoptosis of the neurons and did not increase the bcl 2 expression as well.MK 801 treated group,NAC treated group and cocktail treated group significantly decreased the apoptosis of the neurons and increased the bcl 2 expression (P< 0.05,F test).With cocktail treated group showing more distinct effect (P< 0.05,F test).CONCLUSION:Cocktail may be more effective than single neuroprotectant in this modle. 展开更多
关键词 神经保护剂 鸡尾酒疗法 大鼠 局灶性脑缺血
下载PDF
Brain natriuretic peptide and optimal management of heart failure 被引量:2
18
作者 李楠 王建安 《Journal of Zhejiang University-Science B(Biomedicine & Biotechnology)》 SCIE EI CAS CSCD 2005年第9期877-884,共8页
Aside from the important role of brain natriuretic peptide (BNP) in diagnosis, and differential diagnosis of heart failure, this biological peptide has proved to be an independent surrogate marker of rehospitalization... Aside from the important role of brain natriuretic peptide (BNP) in diagnosis, and differential diagnosis of heart failure, this biological peptide has proved to be an independent surrogate marker of rehospitalization and death of the fatal disease. Several randomized clinical trials demonstrated that drugs such as beta blocker, angiotensin converting enzyme inhibitor, spiro- nolactone and amiodarone have beneficial effects in decreasing circulating BNP level during the management of chronic heart failure. The optimization of clinical decision-making appeals for a representative surrogate marker for heart failure prognosis. The serial point-of-care assessments of BNP concentration provide a therapeutic goal of clinical multi-therapy and an objective guid- ance for optimal treatment of heart failure. Nevertheless new questions and problems in this area remain to be clarified. On the basis of current research advances, this article gives an overview of BNP peptide and its property and role in the management of heart failure. 展开更多
关键词 脑纳素 心脏疾病 麻醉术 治疗方法
下载PDF
Gene therapy with caspase-3 small interfering RNA-nanoparticles is neuroprotective after optic nerve damage
19
作者 Mohamed Tawfik Xiwei Zhang +5 位作者 Lisa Grigartzik Peter Heiduschka Werner Hintz Petra Henrich-Noack Berend van Wachem Bernhard A.Sabel 《Neural Regeneration Research》 SCIE CAS CSCD 2021年第12期2534-2541,共8页
Apoptosis,a key mechanism of programmed cell death,is triggered by caspase-3 protein and lowering its levels with gene therapy may rescue cell death after central nervous system damage.We developed a novel,non-viral g... Apoptosis,a key mechanism of programmed cell death,is triggered by caspase-3 protein and lowering its levels with gene therapy may rescue cell death after central nervous system damage.We developed a novel,non-viral gene therapy to block caspase-3 gene expression using small interfering RNA(siRNA)delivered by polybutylcyanoacrylate nanoparticles(CaspNPs).In vitro CaspNPs significantly blocked caspase-3 protein expression in C6 cells,and when injected intraocularly in vivo,CaspNPs lowered retinal capsase-3 immunofluorescence by 57.9%in rats with optic nerve crush.Longitudinal,repeated retinal ganglion cell counts using confocal neuroimaging showed that post-traumatic cell loss after intraocular CaspNPs injection was only 36.1%versus 63.4%in lesioned controls.Because non-viral gene therapy with siRNA-nanoparticles can selectively silence caspace-3 gene expression and block apoptosis in post-mitotic neurons,siRNA delivery with nanoparticles may be promising for neuroprotection or restoration of central visual system damage and other neurological disorders.The animal study procedures were approved by the German National Act on the use of experimental animals(Ethic Committee Referat Verbraucherschutz,Veterinärangelegenheiten;Landesverwaltungsamt Sachsen-Anhalt,Halle,Germany,#IMP/G/01-1150/12 and#IMP/G/01-1469/17). 展开更多
关键词 apoptosis brain CASPASE-3 drug delivery gene therapy in vivo confocal neuroimaging NANOPARTICLES NEURODEGENERATION neuroprotection retina siRNA
下载PDF
Brainstem abscesses caused by Listeria monocytogenes:A case report
20
作者 Jie Wang Yu-Chen Li +2 位作者 Ke-Yu Yang Jing Wang Zan Dong 《World Journal of Clinical Cases》 SCIE 2022年第22期7924-7930,共7页
BACKGROUNDIntracranial Listeria infections are common in newborns and immunocompromisedindividuals, but brainstem abscesses are rare.CASE SUMMARYWe report a rare case of brainstem abscesses caused by Listeria monocyto... BACKGROUNDIntracranial Listeria infections are common in newborns and immunocompromisedindividuals, but brainstem abscesses are rare.CASE SUMMARYWe report a rare case of brainstem abscesses caused by Listeria monocytogenes in apreviously healthy adult patient. The patient’s magnetic resonance imagingexamination showed multiple brain abscesses, and his second cerebrospinal fluidculture test indicated the presence of Listeria monocytogenes. Despite earlyempirical therapy, the patient’s condition progressively deteriorated. Because thepatient's abscesses were located in the brainstem and multiple lobes, surgery wasnot possible. The patient died 40 d after admission.CONCLUSIONThis case highlights the importance of rational clinical use of drugs to avoidpotentially serious infectious complications. 展开更多
关键词 Listeria monocytogenes brainstem abscesses drug brain MRI therapy PROGNOSIS Case report
下载PDF
上一页 1 2 33 下一页 到第
使用帮助 返回顶部